Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Return on Sales: 2020-2022

Historic Return on Sales for Therapeutics (RAPT) over the last 1 years, with Jun 2022 value amounting to -23.47%.

  • Therapeutics' Return on Sales fell 1128.00% to -23.47% in Q2 2022 from the same period last year, while for Jun 2022 it was -23.47%, marking a year-over-year decrease of 1128.00%. This contributed to the annual value of -56.19% for FY2022, which is 3804.00% down from last year.
  • Per Therapeutics' latest filing, its Return on Sales stood at -23.47% for Q2 2022, which was down 3.27% from -22.73% recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Return on Sales ranged from a high of -10.49% in Q4 2020 and a low of -23.47% during Q2 2022.
  • Its 3-year average for Return on Sales is -16.04%, with a median of -14.68% in 2021.
  • Data for Therapeutics' Return on Sales shows a maximum YoY crashed of 1,217bps (in 2022) over the last 5 years.
  • Therapeutics' Return on Sales (Quarterly) stood at -10.49% in 2020, then plummeted by 766bps to -18.15% in 2021, then tumbled by 1,128bps to -23.47% in 2022.
  • Its Return on Sales stands at -23.47% for Q2 2022, versus -22.73% for Q1 2022 and -18.15% for Q4 2021.